finasteride ๐Ÿถ Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
testosterone reductase inhibitors 1171 98319-26-7

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • finasteride
  • finastid
  • prosteride
  • prostide
  • propecia
An orally active 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE inhibitor. It is used as a surgical alternative for treatment of benign PROSTATIC HYPERPLASIA.
  • Molecular weight: 372.55
  • Formula: C23H36N2O2
  • CLOGP: 3.01
  • LIPINSKI: 0
  • HAC: 4
  • HDO: 2
  • TPSA: 58.20
  • ALOGS: -5.27
  • ROTB: 2

  • Status: OFP

  • Legend:
    OFP - off patent
    OFM - off market
    ONP - on patent

Drug dosage:

DoseUnitRoute
1 mg O
5 mg O

ADMET properties:

PropertyValueReference
BDDCS (Biopharmaceutical Drug Disposition Classification System) 2 Bocci G, Oprea TI, Benet LZ
S (Water solubility) 0.01 mg/mL Bocci G, Oprea TI, Benet LZ
EoM (Fraction excreted unchanged in urine) 0.50 % Benet LZ, Broccatelli F, Oprea TI
MRTD (Maximum Recommended Therapeutic Daily Dose) 0.19 ยตM/kg/day Contrera JF, Matthews EJ, Kruhlak NL, Benz RD
BA (Bioavailability) 63 % Kim MT, Sedykh A, Chakravarti SK, Saiakhov RD, Zhu H
Vd (Volume of distribution) 1.10 L/kg Lombardo F, Berellini G, Obach RS
CL (Clearance) 2.40 mL/min/kg Lombardo F, Berellini G, Obach RS
fu (Fraction unbound in plasma) 0.10 % Lombardo F, Berellini G, Obach RS
t_half (Half-life) 6 hours Lombardo F, Berellini G, Obach RS

Approvals:

DateAgencyCompanyOrphan
June 19, 1992 FDA MERCK

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Exposure via body fluid 312.91 24.64 44 1339 572 63487067
Exposure during pregnancy 125.83 24.64 63 1320 155484 63332155
Abortion spontaneous 89.92 24.64 35 1348 47160 63440479
Product administration error 70.19 24.64 24 1359 22373 63465266
Abortion induced 56.99 24.64 17 1366 10225 63477414
Paternal drugs affecting foetus 53.01 24.64 7 1376 54 63487585
Exposure via father 42.55 24.64 7 1376 265 63487374
Hypertrichosis 38.15 24.64 8 1375 1146 63486493
Trans-sexualism 36.71 24.64 4 1379 3 63487636
Temporal lobe epilepsy 33.07 24.64 6 1377 405 63487234
No adverse event 31.00 24.64 16 1367 41389 63446250
Hidradenitis 30.97 24.64 8 1375 2838 63484801
Ophthalmoplegia 30.79 24.64 7 1376 1457 63486182
White matter lesion 28.99 24.64 7 1376 1888 63485751
Skin induration 25.30 24.64 7 1376 3216 63484423
Nystagmus 24.78 24.64 8 1375 6212 63481427

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Sexual dysfunction 2882.85 10.68 919 82271 5384 34868357
Erectile dysfunction 2517.04 10.68 1145 82045 19492 34854249
Libido decreased 1504.99 10.68 524 82666 4172 34869569
Loss of libido 1240.24 10.68 390 82800 2162 34871579
Semen volume decreased 937.80 10.68 208 82982 148 34873593
Ejaculation disorder 886.33 10.68 244 82946 765 34872976
Depression 773.11 10.68 1049 82141 96049 34777692
Cognitive disorder 709.33 10.68 570 82620 28123 34845618
Penile size reduced 552.74 10.68 121 83069 74 34873667
Anxiety 551.07 10.68 907 82283 98521 34775220
Ejaculation failure 549.30 10.68 160 83030 649 34873092
Testicular pain 516.77 10.68 209 82981 2609 34871132
Post 5-alpha-reductase inhibitor syndrome 454.39 10.68 94 83096 22 34873719
Organic erectile dysfunction 446.70 10.68 107 83083 149 34873592
Gynaecomastia 427.43 10.68 279 82911 9901 34863840
Hypogonadism 405.77 10.68 165 83025 2090 34871651
Blood testosterone decreased 361.53 10.68 186 83004 4171 34869570
Hormone level abnormal 359.15 10.68 99 83091 312 34873429
Testicular atrophy 269.05 10.68 86 83104 506 34873235
Penis injury 263.99 10.68 71 83119 198 34873543
Varicocele 257.53 10.68 55 83135 24 34873717
Painful ejaculation 241.11 10.68 51 83139 19 34873722
Genital hypoaesthesia 226.83 10.68 61 83129 170 34873571
Penis disorder 214.92 10.68 89 83101 1184 34872557
Off label use 201.41 10.68 438 82752 419086 34454655
Testicular failure 192.27 10.68 42 83148 25 34873716
Testicular disorder 176.17 10.68 68 83122 743 34872998
Semen analysis abnormal 166.82 10.68 34 83156 5 34873736
Orgasm abnormal 166.64 10.68 43 83147 96 34873645
Benign prostatic hyperplasia 163.72 10.68 187 83003 14308 34859433
Male orgasmic disorder 162.94 10.68 41 83149 79 34873662
Endocrine disorder 155.97 10.68 49 83141 270 34873471
Hypogonadism male 155.59 10.68 50 83140 300 34873441
Androgen deficiency 153.95 10.68 44 83146 164 34873577
Epididymal cyst 150.57 10.68 34 83156 29 34873712
Pyrexia 149.56 10.68 360 82830 332653 34541088
Infertility male 148.78 10.68 42 83148 148 34873593
Toxicity to various agents 147.14 10.68 156 83034 200206 34673535
Prostatitis 143.61 10.68 113 83077 5394 34868347
Hair transplant 141.23 10.68 30 83160 12 34873729
Panic attack 140.64 10.68 141 83049 9291 34864450
Male reproductive tract disorder 140.33 10.68 37 83153 93 34873648
Product administration error 137.87 10.68 182 83008 16162 34857579
Suicidal ideation 137.84 10.68 300 82890 40088 34833653
Sperm concentration decreased 115.46 10.68 33 83157 123 34873618
Drug ineffective 109.19 10.68 640 82550 456111 34417630
Anorgasmia 108.83 10.68 49 83141 808 34872933
Right atrial hypertrophy 108.54 10.68 48 83142 757 34872984
Reproductive tract disorder 105.91 10.68 21 83169 0 34873741
Drug abuse 95.27 10.68 59 83131 99037 34774704
Wrong technique in product usage process 94.14 10.68 241 82949 35745 34837996
Orgasmic sensation decreased 93.81 10.68 24 83166 51 34873690
Brain injury 93.74 10.68 93 83097 6049 34867692
Premature ejaculation 93.57 10.68 27 83163 105 34873636
Infertility 92.11 10.68 30 83160 189 34873552
Prostatic pain 90.63 10.68 25 83165 79 34873662
Male genital atrophy 90.62 10.68 19 83171 6 34873735
Muscle atrophy 89.54 10.68 99 83091 7305 34866436
Penile curvature 88.36 10.68 25 83165 89 34873652
Febrile neutropenia 88.14 10.68 118 83072 136731 34737010
Vomiting 85.90 10.68 302 82888 247319 34626422
Bronchial secretion retention 84.46 10.68 50 83140 1486 34872255
Urine flow decreased 83.16 10.68 46 83144 1198 34872543
Vasectomy 82.22 10.68 20 83170 31 34873710
Disturbance in sexual arousal 81.92 10.68 25 83165 123 34873618
Right ventricular hypertrophy 81.91 10.68 49 83141 1485 34872256
Urinary retention 81.79 10.68 230 82960 36058 34837683
Breast enlargement 81.45 10.68 34 83156 462 34873279
Gastrooesophageal reflux disease 81.23 10.68 236 82954 37688 34836053
Bronchial wall thickening 76.45 10.68 45 83145 1323 34872418
Intervertebral disc degeneration 76.22 10.68 85 83105 6332 34867409
Penile pain 75.95 10.68 47 83143 1516 34872225
Dizziness 75.86 10.68 824 82366 217697 34656044
Multiple organ dysfunction syndrome 75.80 10.68 44 83146 76522 34797219
Aortic valve stenosis 71.63 10.68 56 83134 2647 34871094
Obstruction 71.34 10.68 56 83134 2663 34871078
Disturbance in attention 71.23 10.68 177 83013 25768 34847973
Foetal exposure during pregnancy 71.23 10.68 5 83185 38096 34835645
Sleep apnoea syndrome 70.50 10.68 152 83038 20169 34853572
Tonsillectomy 70.28 10.68 29 83161 382 34873359
Insomnia 69.99 10.68 455 82735 103452 34770289
Interstitial lung disease 69.79 10.68 34 83156 65248 34808493
Breast cancer 69.13 10.68 26 83164 263 34873478
Hyperlipidaemia 66.45 10.68 122 83068 14407 34859334
Genital atrophy 65.56 10.68 13 83177 0 34873741
Breast tenderness 64.20 10.68 33 83157 738 34873003
Testicular cyst 63.31 10.68 17 83173 47 34873694
Major depression 62.08 10.68 65 83125 4507 34869234
Condition aggravated 61.61 10.68 242 82948 191954 34681787
Haematospermia 61.37 10.68 25 83165 318 34873423
Breast mass 60.94 10.68 30 83160 610 34873131
Melanocytic naevus 60.90 10.68 48 83142 2296 34871445
Fatigue 60.77 10.68 1227 81963 369426 34504315
Adverse event 60.73 10.68 137 83053 18740 34855001
Pollakiuria 60.22 10.68 140 83050 19534 34854207
Dysuria 58.16 10.68 169 83021 26983 34846758
Neutropenia 57.84 10.68 186 83004 156592 34717149
Spermatocele 57.05 10.68 14 83176 23 34873718
Pulmonary function test abnormal 56.37 10.68 48 83142 2562 34871179
Dihydrotestosterone decreased 55.48 10.68 11 83179 0 34873741
Lower urinary tract symptoms 55.19 10.68 21 83169 220 34873521
Nocturia 54.82 10.68 92 83098 10118 34863623
Male sexual dysfunction 54.71 10.68 22 83168 270 34873471
Prostatomegaly 52.18 10.68 64 83126 5277 34868464
Azoospermia 52.17 10.68 24 83166 417 34873324
Generalised anxiety disorder 51.48 10.68 29 83161 783 34872958
Epididymitis 50.63 10.68 44 83146 2415 34871326
Semen viscosity decreased 50.43 10.68 10 83180 0 34873741
Somatic symptom disorder 50.21 10.68 27 83163 664 34873077
Product use in unapproved indication 50.19 10.68 130 83060 117369 34756372
Haematuria 50.14 10.68 244 82946 49822 34823919
Blood oestrogen increased 50.11 10.68 14 83176 47 34873694
Oligospermia 49.51 10.68 16 83174 98 34873643
Fall 48.88 10.68 715 82475 202170 34671571
Wisdom teeth removal 48.83 10.68 16 83174 103 34873638
Marital problem 48.41 10.68 14 83176 55 34873686
Arthroscopy 47.25 10.68 15 83175 86 34873655
Orthostatic hypotension 46.82 10.68 152 83038 25767 34847974
Septic shock 46.14 10.68 62 83128 71772 34801969
Sepsis 45.87 10.68 222 82968 166339 34707402
C-reactive protein increased 45.66 10.68 37 83153 54061 34819680
Body fat disorder 45.58 10.68 13 83177 48 34873693
Amnesia 45.50 10.68 153 83037 26410 34847331
Dark circles under eyes 45.37 10.68 13 83177 49 34873692
Genital paraesthesia 45.28 10.68 12 83178 31 34873710
Nausea 44.84 10.68 556 82634 339352 34534389
Self esteem decreased 44.68 10.68 23 83167 516 34873225
Mucosal inflammation 44.60 10.68 18 83172 38604 34835137
Intentional product use issue 44.44 10.68 46 83144 59770 34813971
Breast cancer male 44.24 10.68 21 83169 393 34873348
Hypoacusis 43.47 10.68 110 83080 16191 34857550
Attention deficit hyperactivity disorder 43.28 10.68 41 83149 2518 34871223
Soft tissue injury 43.15 10.68 17 83173 197 34873544
Cardiac arrest 42.92 10.68 104 83086 96055 34777686
Overdose 42.63 10.68 96 83094 90963 34782778
Hepatic vein dilatation 41.82 10.68 17 83173 215 34873526
Hypospermia 41.31 10.68 10 83180 15 34873726
Hormone receptor positive breast cancer 41.07 10.68 11 83179 30 34873711
Breast pain 40.94 10.68 31 83159 1397 34872344
Prostatic disorder 40.73 10.68 45 83145 3317 34870424
Secondary hypogonadism 40.69 10.68 18 83172 284 34873457
Treatment failure 40.59 10.68 31 83159 46666 34827075
Intentional overdose 40.58 10.68 27 83163 43647 34830094
Terminal dribbling 40.35 10.68 8 83182 0 34873741
Androgens abnormal 40.35 10.68 8 83182 0 34873741
Teratospermia 40.35 10.68 8 83182 0 34873741
Osteoporosis 39.70 10.68 91 83099 12577 34861164
Anogenital warts 39.70 10.68 22 83168 575 34873166
Metabolic acidosis 39.26 10.68 28 83162 43652 34830089
Libido disorder 39.15 10.68 17 83173 256 34873485
Chest X-ray abnormal 38.67 10.68 50 83140 4348 34869393
Skin atrophy 38.17 10.68 35 83155 2062 34871679
Knee operation 38.17 10.68 35 83155 2062 34871679
Scrotal disorder 37.73 10.68 14 83176 136 34873605
Patellofemoral pain syndrome 37.73 10.68 14 83176 136 34873605
Spermatozoa abnormal 37.68 10.68 11 83179 45 34873696
Stress at work 37.58 10.68 16 83174 229 34873512
Partner stress 37.46 10.68 14 83176 139 34873602
Diastolic dysfunction 37.35 10.68 59 83131 6168 34867573
Radical prostatectomy 37.30 10.68 11 83179 47 34873694
Completed suicide 37.20 10.68 115 83075 98053 34775688
Respiratory failure 37.15 10.68 133 83057 108439 34765302
Tachycardia 36.79 10.68 93 83097 84679 34789062
Cytomegalovirus infection 35.82 10.68 9 83181 26126 34847615
Malignant neoplasm progression 35.63 10.68 100 83090 87946 34785795
Persistent depressive disorder 35.53 10.68 17 83173 324 34873417
Ascites 35.52 10.68 35 83155 46536 34827205
Feeling abnormal 35.52 10.68 265 82925 62970 34810771
Mole excision 35.30 10.68 7 83183 0 34873741
Apathy 35.28 10.68 61 83129 6871 34866870
Cytokine release syndrome 35.22 10.68 6 83184 22871 34850870
Cardio-respiratory arrest 35.19 10.68 48 83142 55225 34818516
Dehydroepiandrosterone decreased 34.91 10.68 9 83181 20 34873721
Leukopenia 34.82 10.68 60 83130 62796 34810945
Sexually transmitted disease 34.60 10.68 9 83181 21 34873720
Emotional distress 34.59 10.68 96 83094 14930 34858811
Blood thyroid stimulating hormone decreased 34.56 10.68 32 83158 1909 34871832
Chronic fatigue syndrome 34.17 10.68 17 83173 354 34873387
Arterial insufficiency 34.01 10.68 13 83177 138 34873603
Psychosexual disorder 33.95 10.68 12 83178 100 34873641
Infusion related reaction 33.86 10.68 46 83144 53011 34820730
Panic disorder 33.27 10.68 26 83164 1228 34872513
Blood luteinising hormone decreased 33.14 10.68 12 83178 108 34873633
Breast disorder male 33.04 10.68 8 83182 12 34873729
Disseminated intravascular coagulation 32.98 10.68 6 83184 21810 34851931
Perineal pain 32.93 10.68 22 83168 811 34872930
Nipple pain 32.90 10.68 23 83167 914 34872827
Nasal septal operation 32.80 10.68 10 83180 49 34873692
Hydrocele 32.59 10.68 32 83158 2055 34871686
Social anxiety disorder 32.12 10.68 16 83174 334 34873407
Nasal septum deviation 31.82 10.68 24 83166 1075 34872666
Spermatozoa progressive motility decreased 31.68 10.68 12 83178 124 34873617
Semen discolouration 31.60 10.68 8 83182 16 34873725
Liver palpable 31.58 10.68 15 83175 281 34873460
Muscle strain 31.57 10.68 43 83147 3933 34869808
Seizure 31.07 10.68 136 83054 104721 34769020
Hernia repair 30.81 10.68 25 83165 1247 34872494
Drug interaction 30.71 10.68 367 82823 225579 34648162
Alanine aminotransferase increased 30.38 10.68 95 83095 80720 34793021
Testicular microlithiasis 30.37 10.68 8 83182 20 34873721
Varicocele repair 30.26 10.68 6 83184 0 34873741
Granulomatous rosacea 30.08 10.68 12 83178 144 34873597
Renal failure 29.88 10.68 185 83005 130372 34743369
Macular hole 29.40 10.68 13 83177 205 34873536
Drug hypersensitivity 29.33 10.68 96 83094 80433 34793308
Sleep disorder 29.29 10.68 151 83039 31537 34842204
Ejaculation delayed 29.20 10.68 14 83176 268 34873473
Essential hypertension 28.93 10.68 36 83154 3012 34870729
Rhinitis allergic 28.91 10.68 36 83154 3014 34870727
Hypotrichosis 28.60 10.68 8 83182 27 34873714
Urinary tract obstruction 28.51 10.68 39 83151 3581 34870160
Irritable bowel syndrome 28.32 10.68 39 83151 3604 34870137
Saliva altered 27.56 10.68 12 83178 182 34873559
Platypnoea 27.55 10.68 8 83182 32 34873709
Genital pain 27.44 10.68 16 83174 462 34873279
Thrombocytopenia 27.31 10.68 239 82951 156008 34717733
Lid sulcus deepened 27.20 10.68 9 83181 60 34873681
Serotonin syndrome 27.05 10.68 7 83183 19926 34853815
Rotator cuff repair 27.04 10.68 14 83176 318 34873423
Acute respiratory distress syndrome 27.03 10.68 14 83176 25955 34847786
Adenotonsillectomy 26.98 10.68 8 83182 35 34873706
Emotional poverty 26.59 10.68 17 83173 581 34873160
Psychiatric symptom 26.40 10.68 37 83153 3476 34870265
Pelvic pain 26.33 10.68 31 83159 2449 34871292
Dermal cyst 26.17 10.68 27 83163 1840 34871901
Primary hypogonadism 26.01 10.68 9 83181 70 34873671
Renal impairment 25.97 10.68 126 83064 94387 34779354
Urinary tract infection 25.88 10.68 310 82880 83771 34789970
Skin irritation 25.71 10.68 47 83143 5530 34868211
Respiratory depression 25.59 10.68 4 83186 16241 34857500
Product use issue 25.42 10.68 72 83118 63144 34810597
Hypercholesterolaemia 25.34 10.68 61 83129 8701 34865040
Disease progression 25.32 10.68 152 83038 107925 34765816
Liposuction 25.22 10.68 5 83185 0 34873741
Leydig cell tumour of the testis 25.22 10.68 5 83185 0 34873741
Psychogenic erectile dysfunction 25.22 10.68 5 83185 0 34873741
Shock 25.22 10.68 13 83177 24166 34849575
Suicide attempt 24.87 10.68 34 83156 39082 34834659
Respiratory distress 24.75 10.68 29 83161 35636 34838105
Vitamin D deficiency 24.74 10.68 51 83139 6557 34867184
Inguinal hernia repair 24.69 10.68 13 83177 306 34873435
Prostatic specific antigen increased 24.65 10.68 84 83106 14596 34859145
Penile vascular disorder 24.40 10.68 6 83184 10 34873731
Genital lesion 24.29 10.68 12 83178 246 34873495
Platelet distribution width increased 24.08 10.68 10 83180 134 34873607
Ligament sprain 24.07 10.68 35 83155 3402 34870339
Hepatic failure 24.05 10.68 28 83162 34503 34839238
Pneumonia 23.88 10.68 669 82521 361958 34511783
Prostatic operation 23.83 10.68 14 83176 410 34873331
Testicular mass 23.59 10.68 9 83181 95 34873646
Skin papilloma 23.52 10.68 27 83163 2076 34871665
Oestradiol increased 23.48 10.68 8 83182 59 34873682
Bone marrow failure 23.46 10.68 21 83169 29232 34844509
Diabetic ketoacidosis 23.23 10.68 7 83183 18025 34855716
Hallucination 23.06 10.68 205 82985 51293 34822448
Appendicectomy 22.94 10.68 20 83170 1102 34872639
Shoulder operation 22.88 10.68 20 83170 1106 34872635
Physical disability 22.87 10.68 22 83168 1377 34872364
Radiotherapy to prostate 22.87 10.68 5 83185 3 34873738
Seborrhoeic keratosis 22.72 10.68 21 83169 1250 34872491
Rheumatoid arthritis 22.58 10.68 35 83155 38203 34835538
Stomatitis 22.27 10.68 42 83148 42472 34831269
Asthenia 22.15 10.68 751 82439 244500 34629241
Anhedonia 22.15 10.68 53 83137 7532 34866209
Rash maculo-papular 22.14 10.68 21 83169 28430 34845311
Renal cyst 21.83 10.68 59 83131 9034 34864707
Injection site pain 21.81 10.68 37 83153 38968 34834773
Feminisation acquired 21.78 10.68 7 83183 42 34873699
Benign neoplasm of skin 21.64 10.68 9 83181 121 34873620
Orchitis 21.60 10.68 23 83167 1626 34872115
Epicondylitis 21.55 10.68 14 83176 492 34873249
Androgen insensitivity syndrome 21.51 10.68 6 83184 20 34873721
Lactic acidosis 21.33 10.68 31 83159 34741 34839000
Cerumen impaction 21.32 10.68 13 83177 408 34873333
Erythema 21.25 10.68 124 83066 88656 34785085
Bronchiectasis 20.98 10.68 61 83129 9740 34864001
Seborrhoeic dermatitis 20.93 10.68 23 83167 1685 34872056
Diverticulum 20.88 10.68 50 83140 7109 34866632
Blood follicle stimulating hormone decreased 20.86 10.68 7 83183 49 34873692
Mastectomy 20.86 10.68 6 83184 23 34873718
Blood testosterone increased 20.78 10.68 20 83170 1253 34872488
Inferior vena cava dilatation 20.69 10.68 16 83174 744 34872997
Toxic epidermal necrolysis 20.62 10.68 13 83177 21633 34852108
Agranulocytosis 20.46 10.68 16 83174 23805 34849936
Bladder neck obstruction 20.35 10.68 9 83181 142 34873599
Drug resistance 20.33 10.68 19 83171 25908 34847833
Drug ineffective for unapproved indication 20.28 10.68 16 83174 23699 34850042
Daydreaming 20.26 10.68 14 83176 546 34873195
Benign tumour excision 20.17 10.68 4 83186 0 34873741
Late onset hypogonadism syndrome 20.17 10.68 4 83186 0 34873741
Pelvic floor muscle weakness 20.17 10.68 4 83186 0 34873741
Oestrogenic effect 20.17 10.68 4 83186 0 34873741
Blood follicle stimulating hormone abnormal 20.17 10.68 4 83186 0 34873741
Sex hormone binding globulin increased 20.09 10.68 5 83185 9 34873732
Pneumocystis jirovecii pneumonia 19.96 10.68 11 83179 19699 34854042
Palpitations 19.91 10.68 163 83027 39823 34833918
Haemorrhoids 19.91 10.68 78 83112 14497 34859244
Acrochordon 19.70 10.68 12 83178 376 34873365
Memory impairment 19.68 10.68 173 83017 43145 34830596
Illusion 19.50 10.68 16 83174 811 34872930
Seminoma 19.32 10.68 10 83180 227 34873514
Cystitis 19.22 10.68 59 83131 9706 34864035
Lipoma 19.03 10.68 22 83168 1704 34872037
Bladder outlet obstruction 19.03 10.68 9 83181 167 34873574
Epilepsy 19.02 10.68 14 83176 21481 34852260
Seborrhoea 18.85 10.68 10 83180 239 34873502
Balance disorder 18.80 10.68 163 83027 40491 34833250
Prostatic calcification 18.76 10.68 8 83182 115 34873626
Blood testosterone free decreased 18.68 10.68 7 83183 70 34873671
Alveolar bone resorption 18.57 10.68 5 83185 14 34873727
Neutrophil count decreased 18.55 10.68 61 83129 51043 34822698
Extrapyramidal disorder 18.51 10.68 4 83186 12876 34860865
Anxiety disorder 18.34 10.68 22 83168 1772 34871969
Hepatic function abnormal 18.22 10.68 50 83140 44313 34829428
Pancreatitis 18.19 10.68 41 83149 38850 34834891
Ventricular enlargement 18.12 10.68 14 83176 650 34873091
Cardiogenic shock 18.09 10.68 22 83168 26596 34847145
Seasonal affective disorder 18.08 10.68 5 83185 16 34873725
Atrial enlargement 17.97 10.68 14 83176 658 34873083
Testis discomfort 17.94 10.68 4 83186 3 34873738
Blunted affect 17.94 10.68 11 83179 349 34873392
Atrial fibrillation 17.91 10.68 399 82791 121994 34751747
Nephropathy toxic 17.91 10.68 4 83186 12584 34861157
Inner ear disorder 17.89 10.68 9 83181 192 34873549
Genital burning sensation 17.85 10.68 5 83185 17 34873724
Ventricular fibrillation 17.79 10.68 17 83173 22937 34850804
Plica syndrome 17.41 10.68 4 83186 4 34873737
Genital cyst 17.41 10.68 4 83186 4 34873737
Melanocytic hyperplasia 17.41 10.68 4 83186 4 34873737
Keratomileusis 17.41 10.68 4 83186 4 34873737
Hypothalamo-pituitary disorder 17.39 10.68 15 83175 815 34872926
Back injury 17.31 10.68 33 83157 4008 34869733
Sex hormone binding globulin decreased 17.22 10.68 5 83185 20 34873721
Lymphadenectomy 17.20 10.68 11 83179 376 34873365
Malpositioned teeth 17.02 10.68 5 83185 21 34873720
Xanthopsia 16.98 10.68 8 83182 147 34873594
Thinking abnormal 16.98 10.68 42 83148 6095 34867646
Cholecystectomy 16.94 10.68 27 83163 2843 34870898
Flat affect 16.87 10.68 15 83175 849 34872892
Acute kidney injury 16.79 10.68 576 82614 304412 34569329
Affective disorder 16.73 10.68 34 83156 4326 34869415
Lung disorder 16.70 10.68 36 83154 34660 34839081
Facial bones fracture 16.69 10.68 25 83165 2495 34871246
Myocardial infarction 16.67 10.68 196 82994 120889 34752852
Bronchopulmonary aspergillosis 16.65 10.68 7 83183 14652 34859089
Sprue-like enteropathy 16.65 10.68 12 83178 501 34873240
Cardiac failure 16.63 10.68 138 83052 91110 34782631
Aspartate aminotransferase increased 16.57 10.68 94 83096 67689 34806052
Rhinoplasty 16.52 10.68 4 83186 6 34873735
Benign breast neoplasm 16.52 10.68 4 83186 6 34873735
Penile prosthesis insertion 16.52 10.68 4 83186 6 34873735
Pelvic discomfort 16.52 10.68 4 83186 6 34873735
Pudendal canal syndrome 16.52 10.68 4 83186 6 34873735
Decreased interest 16.48 10.68 24 83166 2336 34871405
Dissociation 16.41 10.68 20 83170 1638 34872103
Xerophthalmia 16.39 10.68 7 83183 101 34873640
Obsessive-compulsive disorder 16.37 10.68 39 83151 5525 34868216
Micturition urgency 16.33 10.68 43 83147 6482 34867259
Milia 16.32 10.68 5 83185 25 34873716
Rosacea 16.27 10.68 17 83173 1176 34872565
Fat tissue increased 16.26 10.68 11 83179 414 34873327
Scrotal pain 16.25 10.68 15 83175 891 34872850
Limb operation 16.24 10.68 14 83176 760 34872981
Impaired fasting glucose 16.18 10.68 9 83181 237 34873504
Drug reaction with eosinophilia and systemic symptoms 16.10 10.68 34 83156 32978 34840763
Retrograde ejaculation 16.08 10.68 11 83179 422 34873319
Blood pressure fluctuation 15.99 10.68 22 83168 25227 34848514
Agoraphobia 15.98 10.68 9 83181 243 34873498
Muscle disorder 15.95 10.68 25 83165 2596 34871145
Joint injury 15.85 10.68 53 83137 9120 34864621
Gingival recession 15.81 10.68 11 83179 434 34873307
Type V hyperlipidaemia 15.78 10.68 14 83176 790 34872951
Asthenospermia 15.67 10.68 6 83184 64 34873677
Mental impairment 15.55 10.68 57 83133 10265 34863476
Acute hepatic failure 15.54 10.68 7 83183 14067 34859674
Groin pain 15.54 10.68 38 83152 5475 34868266
Drug-induced liver injury 15.53 10.68 28 83162 28804 34844937
Penile exfoliation 15.51 10.68 7 83183 116 34873625
Product name confusion 15.51 10.68 6 83184 66 34873675
Hypoglycaemia 15.49 10.68 72 83118 54568 34819173
Chills 15.49 10.68 121 83069 80922 34792819
Hypertrophy 15.46 10.68 11 83179 450 34873291
Bladder disorder 15.43 10.68 28 83162 3276 34870465
Musculoskeletal stiffness 15.41 10.68 58 83132 46622 34827119
Peripheral coldness 15.39 10.68 45 83145 7206 34866535
Depression suicidal 15.39 10.68 24 83166 2481 34871260
Gout 15.26 10.68 88 83102 19165 34854576
Mammoplasty 15.19 10.68 4 83186 10 34873731
Exostosis of external ear canal 15.19 10.68 4 83186 10 34873731
Eyelid cyst 15.13 10.68 3 83187 0 34873741
Varicose vein operation 15.13 10.68 3 83187 0 34873741
Plastic surgery 15.13 10.68 3 83187 0 34873741
Penile repair 15.13 10.68 3 83187 0 34873741
Sigmoidectomy 15.13 10.68 3 83187 0 34873741
Psychophysiologic insomnia 15.13 10.68 3 83187 0 34873741
Urinary bladder suspension 15.13 10.68 3 83187 0 34873741
Benign breast lump removal 15.13 10.68 3 83187 0 34873741
Uvulopalatopharyngoplasty 15.13 10.68 3 83187 0 34873741
Semen liquefaction 15.13 10.68 3 83187 0 34873741
Genital injury 15.13 10.68 3 83187 0 34873741
Dermatitis artefacta 15.13 10.68 3 83187 0 34873741
Lipoma excision 15.13 10.68 3 83187 0 34873741
Interspinous osteoarthritis 15.13 10.68 3 83187 0 34873741
Penile wart 15.13 10.68 3 83187 0 34873741
Biotin deficiency 15.13 10.68 3 83187 0 34873741
Blood oestrogen abnormal 15.13 10.68 3 83187 0 34873741
Scar excision 15.13 10.68 3 83187 0 34873741
Sclerotherapy 15.13 10.68 3 83187 0 34873741
Cryotherapy 15.13 10.68 3 83187 0 34873741
Pseudohermaphroditism male 15.13 10.68 3 83187 0 34873741
Prostate tenderness 15.13 10.68 3 83187 0 34873741
Pancytopenia 15.12 10.68 149 83041 95008 34778733
Prostatic dysplasia 14.91 10.68 4 83186 11 34873730
Soft tissue mass 14.76 10.68 15 83175 1004 34872737
Arthroscopic surgery 14.66 10.68 4 83186 12 34873729
Urinary straining 14.66 10.68 4 83186 12 34873729
Anaphylactic shock 14.61 10.68 10 83180 15931 34857810
Drug dependence 14.45 10.68 22 83168 24195 34849546
Fixed eruption 14.44 10.68 19 83171 1681 34872060
Respiratory arrest 14.43 10.68 28 83162 28015 34845726
Meniscus injury 14.42 10.68 22 83168 2231 34871510
Post-traumatic stress disorder 14.42 10.68 20 83170 1861 34871880
Premature ageing 14.41 10.68 6 83184 81 34873660
Varicose vein 14.41 10.68 17 83173 1346 34872395
Genital herpes 14.38 10.68 12 83178 623 34873118
Dementia Alzheimer's type 14.29 10.68 10 83180 398 34873343
Hypoxia 14.24 10.68 75 83115 55020 34818721
Haemorrhoid operation 14.22 10.68 5 83185 41 34873700
Hair texture abnormal 14.20 10.68 9 83181 303 34873438
Pericarditis 14.15 10.68 5 83185 11640 34862101
Atrioventricular block first degree 14.10 10.68 39 83151 6053 34867688
Tinnitus 14.07 10.68 89 83101 20029 34853712
Adrenal disorder 14.07 10.68 15 83175 1062 34872679
Floppy iris syndrome 14.07 10.68 9 83181 308 34873433
Peritonitis 14.04 10.68 11 83179 16354 34857387
Therapy non-responder 14.02 10.68 47 83143 39099 34834642
Abdominal pain 13.98 10.68 290 82900 163328 34710413
Inguinal hernia 13.96 10.68 45 83145 7596 34866145
Thrombotic microangiopathy 13.92 10.68 4 83186 10626 34863115
General physical health deterioration 13.91 10.68 218 82972 128051 34745690
Prostate cancer 13.91 10.68 150 83040 39499 34834242
Exposure to communicable disease 13.89 10.68 7 83183 150 34873591
Depressed mood 13.85 10.68 86 83104 19231 34854510
Vitreous floaters 13.81 10.68 28 83162 3557 34870184
Eczema 13.80 10.68 83 83107 18353 34855388
Therapy partial responder 13.79 10.68 3 83187 9613 34864128
Madarosis 13.78 10.68 8 83182 229 34873512
Fear of crowded places 13.77 10.68 4 83186 16 34873725
Hyperglycaemia 13.73 10.68 48 83142 39432 34834309
Prostatic specific antigen decreased 13.72 10.68 7 83183 154 34873587
Creatinine urine decreased 13.71 10.68 5 83185 46 34873695
Body height decreased 13.62 10.68 29 83161 3814 34869927
Infusion site induration 13.57 10.68 8 83182 236 34873505
Invasive ductal breast carcinoma 13.53 10.68 5 83185 48 34873693
Abnormal loss of weight 13.51 10.68 30 83160 4060 34869681
Bradyphrenia 13.44 10.68 33 83157 4765 34868976
Electrocardiogram QT prolonged 13.44 10.68 51 83139 40901 34832840
Dyshidrotic eczema 13.44 10.68 7 83183 161 34873580
Beta globulin increased 13.40 10.68 4 83186 18 34873723
Chlamydial infection 13.30 10.68 8 83182 245 34873496
Sinus tachycardia 13.29 10.68 13 83177 17347 34856394
Genital rash 13.25 10.68 11 83179 567 34873174
Urinary tract disorder 13.24 10.68 21 83169 2203 34871538
Red blood cell analysis abnormal 13.22 10.68 4 83186 19 34873722
Reproductive tract hypoplasia, male 13.22 10.68 4 83186 19 34873722
Sexual relationship change 13.22 10.68 4 83186 19 34873722
Gingival disorder 13.22 10.68 17 83173 1470 34872271
Enterococcal infection 13.15 10.68 3 83187 9303 34864438
Oesophageal carcinoma 13.15 10.68 3 83187 9301 34864440
Neoplasm progression 13.12 10.68 22 83168 23278 34850463
Neuroleptic malignant syndrome 13.08 10.68 14 83176 17920 34855821
Coma 13.06 10.68 60 83130 45618 34828123
Otosalpingitis 13.05 10.68 4 83186 20 34873721
Alpha 2 globulin decreased 13.05 10.68 4 83186 20 34873721
Glomerular filtration rate abnormal 13.04 10.68 13 83177 850 34872891
Cystitis radiation 13.00 10.68 6 83184 105 34873636
COVID-19 12.92 10.68 120 83070 77430 34796311
Prostatic haemorrhage 12.90 10.68 8 83182 259 34873482
Free androgen index decreased 12.89 10.68 4 83186 21 34873720
Dry eye 12.88 10.68 51 83139 9524 34864217
Blood follicle stimulating hormone increased 12.88 10.68 7 83183 176 34873565
Orchidectomy 12.84 10.68 5 83185 56 34873685
Social avoidant behaviour 12.81 10.68 25 83165 3089 34870652
Lymphopenia 12.77 10.68 12 83178 16323 34857418
Pneumothorax 12.74 10.68 16 83174 19076 34854665
Viral acanthoma 12.74 10.68 4 83186 22 34873719
Incorrect route of product administration 12.71 10.68 10 83180 14835 34858906
Vision blurred 12.65 10.68 166 83024 45797 34827944
Emotional disorder 12.64 10.68 36 83154 5680 34868061
Full blood count decreased 12.64 10.68 80 83110 18008 34855733
Plantar fascial fibromatosis 12.60 10.68 3 83187 4 34873737
Acne 12.59 10.68 56 83134 11010 34862731
Transurethral prostatectomy 12.59 10.68 9 83181 371 34873370
Posterior reversible encephalopathy syndrome 12.58 10.68 4 83186 9950 34863791
Intervertebral disc protrusion 12.57 10.68 52 83138 9904 34863837
Hyperbilirubinaemia 12.45 10.68 13 83177 16830 34856911
Umbilical hernia repair 12.45 10.68 4 83186 24 34873717
Cortisol increased 12.43 10.68 7 83183 189 34873552
Exposure via body fluid 12.42 10.68 6 83184 117 34873624
Pemphigoid 12.34 10.68 47 83143 8619 34865122
Temperature intolerance 12.33 10.68 26 83164 3396 34870345
Urine calcium/creatinine ratio increased 12.31 10.68 4 83186 25 34873716
Mitral valve prolapse 12.30 10.68 11 83179 627 34873114
Sinus polyp 12.30 10.68 7 83183 193 34873548
Brain oedema 12.23 10.68 9 83181 13812 34859929
Bladder trabeculation 12.20 10.68 3 83187 5 34873736
Motion sickness 12.20 10.68 7 83183 196 34873545
Hepatic cytolysis 12.12 10.68 10 83180 14486 34859255
Proteinuria 12.05 10.68 16 83174 18626 34855115
Bladder stenosis 12.05 10.68 4 83186 27 34873714
Nasal discomfort 12.02 10.68 17 83173 1611 34872130
N-terminal prohormone brain natriuretic peptide abnormal 12.01 10.68 7 83183 202 34873539
Rhabdomyolysis 12.00 10.68 104 83086 68059 34805682
Rales 12.00 10.68 51 83139 9832 34863909
Nipple disorder 11.98 10.68 7 83183 203 34873538
Device related infection 11.98 10.68 14 83176 17223 34856518
C-reactive protein abnormal 11.93 10.68 3 83187 8707 34865034
Prostatic obstruction 11.89 10.68 6 83184 129 34873612
Alpha globulin increased 11.85 10.68 3 83187 6 34873735
Blood testosterone free increased 11.80 10.68 4 83186 29 34873712
Hair growth abnormal 11.80 10.68 12 83178 804 34872937
Delusion of replacement 11.64 10.68 6 83184 135 34873606
Thyroid hormones increased 11.59 10.68 5 83185 74 34873667
Transplant rejection 11.59 10.68 5 83185 10306 34863435
Hepatocellular injury 11.58 10.68 22 83168 22189 34851552
Thyroid cyst 11.57 10.68 4 83186 31 34873710
Snoring 11.57 10.68 25 83165 3321 34870420
Hair colour changes 11.55 10.68 18 83172 1859 34871882
Spermatozoa morphology abnormal 11.53 10.68 3 83187 7 34873734
Mood altered 11.50 10.68 47 83143 8905 34864836
Hyposmia 11.47 10.68 7 83183 220 34873521
Radiotherapy 11.44 10.68 9 83181 429 34873312
Status epilepticus 11.44 10.68 8 83182 12606 34861135
Drug level increased 11.42 10.68 22 83168 22074 34851667
Dandruff 11.28 10.68 7 83183 227 34873514
Uterine haemorrhage 11.25 10.68 3 83187 8 34873733
Pneumonitis 11.24 10.68 42 83148 33836 34839905
Adverse drug reaction 11.23 10.68 113 83077 29229 34844512
Eosinophilia 11.19 10.68 29 83161 26193 34847548
Faeces discoloured 11.15 10.68 67 83123 14811 34858930
Colitis 11.14 10.68 49 83141 37701 34836040
Blood bilirubin increased 11.13 10.68 50 83140 38246 34835495
Adjustment disorder 11.10 10.68 14 83176 1187 34872554
Hepatic cancer 11.05 10.68 3 83187 8272 34865469
Pelvic fracture 11.04 10.68 21 83169 2546 34871195
Pituitary tumour benign 11.03 10.68 12 83178 869 34872872
Hair disorder 11.03 10.68 6 83184 151 34873590
Hospice care 11.03 10.68 39 83151 6901 34866840
Anti factor Xa activity decreased 10.99 10.68 3 83187 9 34873732
Eyelid operation 10.99 10.68 3 83187 9 34873732
Wrist surgery 10.96 10.68 6 83184 153 34873588
Hyponatraemia 10.94 10.68 135 83055 82556 34791185
Myoglobin blood increased 10.93 10.68 23 83167 3000 34870741
Febrile bone marrow aplasia 10.92 10.68 3 83187 8206 34865535
Phobia 10.79 10.68 6 83184 158 34873583
Hepatic enzyme increased 10.78 10.68 52 83138 39028 34834713
Anaphylactic reaction 10.75 10.68 40 83150 32261 34841480
Painful erection 10.73 10.68 7 83183 248 34873493
Cataract operation complication 10.72 10.68 6 83184 160 34873581
Listless 10.69 10.68 16 83174 1596 34872145

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Erectile dysfunction 666.01 10.66 281 54305 14383 79675419
Post 5-alpha-reductase inhibitor syndrome 477.38 10.66 79 54507 22 79689780
Libido decreased 363.76 10.66 137 54449 5184 79684618
Loss of libido 301.58 10.66 100 54486 2585 79687217
Testicular pain 264.69 10.66 85 54501 1980 79687822
Penile size reduced 229.15 10.66 40 54546 30 79689772
Gynaecomastia 199.89 10.66 100 54486 7581 79682221
Right atrial hypertrophy 160.06 10.66 46 54540 725 79689077
Depression 157.75 10.66 412 54174 216378 79473424
Semen volume decreased 156.41 10.66 29 54557 42 79689760
Benign prostatic hyperplasia 148.70 10.66 95 54491 11517 79678285
Ejaculation disorder 133.88 10.66 37 54549 502 79689300
Right ventricular hypertrophy 129.75 10.66 47 54539 1590 79688212
Urinary retention 123.21 10.66 172 54414 56458 79633344
Sexual dysfunction 118.41 10.66 71 54515 7692 79682110
Organic erectile dysfunction 116.23 10.66 24 54562 78 79689724
Haematuria 113.95 10.66 184 54402 68652 79621150
Penis disorder 113.73 10.66 37 54549 899 79688903
Atrial fibrillation 105.07 10.66 336 54250 197550 79492252
Suicidal ideation 100.03 10.66 184 54402 76156 79613646
Infertility male 97.52 10.66 21 54565 88 79689714
Drug ineffective 97.46 10.66 396 54190 1080517 78609285
Obstruction 96.89 10.66 52 54534 4558 79685244
Bronchial wall thickening 95.09 10.66 43 54543 2598 79687204
Genital hypoaesthesia 94.88 10.66 23 54563 178 79689624
Bronchial secretion retention 91.07 10.66 48 54538 4056 79685746
Dizziness 88.68 10.66 640 53946 525801 79164001
Aortic valve stenosis 87.50 10.66 51 54535 5243 79684559
Pulmonary function test abnormal 85.01 10.66 46 54540 4098 79685704
Rheumatoid arthritis 81.60 10.66 21 54565 208449 79481353
Ejaculation failure 81.27 10.66 23 54563 342 79689460
Testicular atrophy 80.90 10.66 23 54563 348 79689454
Blood testosterone decreased 80.23 10.66 37 54549 2340 79687462
Male reproductive tract disorder 76.14 10.66 16 54570 58 79689744
Drug hypersensitivity 73.69 10.66 58 54528 298858 79390944
Orthostatic hypotension 68.13 10.66 131 54455 56033 79633769
Fall 66.12 10.66 564 54022 487065 79202737
Diastolic dysfunction 64.76 10.66 56 54530 10755 79679047
Exposure via body fluid 64.12 10.66 19 54567 335 79689467
Azoospermia 63.37 10.66 16 54570 149 79689653
Chest X-ray abnormal 62.32 10.66 48 54538 7835 79681967
Semen analysis abnormal 60.25 10.66 10 54576 3 79689799
Hallucination 60.25 10.66 161 54425 85584 79604218
Haematospermia 60.06 10.66 17 54569 253 79689549
Off label use 59.99 10.66 370 54216 906845 78782957
Maternal exposure during pregnancy 58.99 10.66 11 54575 136527 79553275
Systemic lupus erythematosus 58.68 10.66 7 54579 121142 79568660
Vomiting 58.48 10.66 246 54340 665582 79024220
Joint swelling 58.28 10.66 67 54519 288579 79401223
Breast cancer male 56.53 10.66 17 54569 316 79689486
Treatment failure 56.43 10.66 23 54563 170463 79519339
Infusion related reaction 56.31 10.66 45 54541 230192 79459610
Intervertebral disc degeneration 55.41 10.66 61 54525 15724 79674078
Cardiac failure congestive 55.08 10.66 218 54368 142184 79547618
Death 55.03 10.66 611 53975 565903 79123899
Hypoacusis 54.58 10.66 84 54502 30066 79659736
Synovitis 53.82 10.66 18 54568 150716 79539086
Drug intolerance 53.65 10.66 61 54525 264058 79425744
Panic attack 53.32 10.66 74 54512 24142 79665660
Prostatic pain 53.21 10.66 11 54575 36 79689766
Pericarditis 53.10 10.66 5 54581 104231 79585571
Hepatic vein dilatation 52.39 10.66 15 54571 233 79689569
Testicular disorder 51.47 10.66 15 54571 249 79689553
Syncope 51.35 10.66 251 54335 179198 79510604
Muscle atrophy 51.32 10.66 50 54536 11182 79678620
Toxicity to various agents 51.22 10.66 135 54451 421405 79268397
Contraindicated product administered 50.93 10.66 22 54564 157516 79532286
Anxiety 50.00 10.66 316 54270 248196 79441606
Prostate cancer 49.76 10.66 85 54501 33183 79656619
Hypospermia 48.97 10.66 9 54577 12 79689790
Swelling 48.58 10.66 46 54540 216665 79473137
Acute kidney injury 48.07 10.66 555 54031 518849 79170953
Pain 48.04 10.66 284 54302 703518 78986284
Prostatitis 47.98 10.66 32 54554 4170 79685632
Penile pain 47.97 10.66 20 54566 991 79688811
Nausea 47.61 10.66 423 54163 956773 78733029
Pyrexia 47.31 10.66 272 54314 678437 79011365
Liver palpable 46.84 10.66 15 54571 346 79689456
Gout 46.28 10.66 70 54516 24679 79665123
International normalised ratio increased 45.94 10.66 145 54441 84576 79605226
Discomfort 44.84 10.66 15 54571 125602 79564200
Prostatic disorder 44.37 10.66 24 54562 2136 79687666
Hepatic enzyme increased 44.26 10.66 36 54550 182574 79507228
Breast tenderness 43.27 10.66 24 54562 2244 79687558
Sleep apnoea syndrome 42.91 10.66 84 54502 36394 79653408
Alopecia 42.20 10.66 58 54528 231297 79458505
Prostatic specific antigen increased 41.51 10.66 43 54543 10343 79679459
Granulomatous rosacea 40.91 10.66 12 54574 204 79689598
Anorgasmia 40.71 10.66 19 54567 1235 79688567
Musculoskeletal stiffness 40.58 10.66 36 54550 174972 79514830
Breast disorder male 39.68 10.66 7 54579 6 79689796
Asthenia 39.67 10.66 529 54057 511160 79178642
Therapeutic product effect decreased 38.85 10.66 33 54553 163830 79525972
Male orgasmic disorder 38.56 10.66 9 54577 58 79689744
Gastrointestinal haemorrhage 38.30 10.66 201 54385 147518 79542284
Arthropathy 38.06 10.66 39 54547 177072 79512730
Wrong technique in product usage process 37.84 10.66 124 54462 73751 79616051
Semen viscosity decreased 37.73 10.66 6 54580 0 79689802
Platypnoea 37.45 10.66 8 54578 32 79689770
Hypotension 36.97 10.66 462 54124 439855 79249947
Stomatitis 36.73 10.66 28 54558 146729 79543073
Helicobacter infection 36.43 10.66 3 54583 69701 79620101
Platelet distribution width increased 36.23 10.66 10 54576 135 79689667
Apathy 35.30 10.66 44 54542 12933 79676869
Hypersensitivity 34.94 10.66 80 54506 262159 79427643
Pemphigoid 34.01 10.66 47 54539 15268 79674534
Inferior vena cava dilatation 33.98 10.66 15 54571 856 79688946
Scrotal disorder 33.96 10.66 8 54578 54 79689748
Dehydroepiandrosterone decreased 33.84 10.66 7 54579 23 79689779
Sinusitis 33.69 10.66 51 54535 195450 79494352
Myoglobin blood increased 33.60 10.66 23 54563 3128 79686674
Spermatozoa abnormal 33.57 10.66 6 54580 6 79689796
Upper gastrointestinal haemorrhage 33.52 10.66 82 54504 41298 79648504
Plasma cell myeloma 33.44 10.66 96 54490 53163 79636639
Urine flow decreased 33.37 10.66 16 54570 1105 79688697
Ventricular enlargement 33.12 10.66 14 54572 718 79689084
Skin atrophy 33.00 10.66 29 54557 5689 79684113
Sperm concentration decreased 32.88 10.66 8 54578 63 79689739
Headache 32.81 10.66 288 54298 653484 79036318
Arrhythmia 32.42 10.66 104 54482 61168 79628634
Leydig cell tumour of the testis 31.44 10.66 5 54581 0 79689802
Dark circles under eyes 31.34 10.66 12 54574 475 79689327
Condition aggravated 31.14 10.66 208 54378 500916 79188886
Hormone receptor positive breast cancer 30.83 10.66 11 54575 356 79689446
Bronchiectasis 30.63 10.66 55 54531 22331 79667471
Lid sulcus deepened 30.57 10.66 9 54577 155 79689647
Emotional poverty 30.54 10.66 14 54572 873 79688929
Disturbance in attention 30.39 10.66 90 54496 50711 79639091
Dysuria 30.22 10.66 90 54496 50861 79638941
Daydreaming 29.87 10.66 14 54572 919 79688883
Genital paraesthesia 29.74 10.66 7 54579 47 79689755
Libido disorder 29.74 10.66 10 54576 270 79689532
Androgen deficiency 29.62 10.66 8 54578 99 79689703
Testis cancer 29.36 10.66 15 54571 1188 79688614
Hypogonadism male 29.36 10.66 9 54577 179 79689623
Blood thyroid stimulating hormone decreased 29.07 10.66 27 54559 5689 79684113
Abdominal discomfort 28.40 10.66 83 54503 250644 79439158
Atrial enlargement 28.38 10.66 14 54572 1029 79688773
Faeces discoloured 28.29 10.66 62 54524 29065 79660737
Pollakiuria 28.18 10.66 72 54514 37245 79652557
Glossodynia 28.13 10.66 18 54568 103319 79586483
Saliva altered 27.51 10.66 11 54575 489 79689313
Injection site pain 27.43 10.66 29 54557 129809 79559993
Rales 27.18 10.66 49 54537 19952 79669850
Body fat disorder 26.91 10.66 9 54577 239 79689563
Intentional product use issue 26.86 10.66 39 54547 152073 79537729
Psychiatric symptom 26.11 10.66 28 54558 7007 79682795
Hepatitis cholestatic 25.64 10.66 39 54547 13813 79675989
Hallucination, visual 25.60 10.66 64 54522 32665 79657137
Fixed eruption 25.59 10.66 19 54567 2935 79686867
Reproductive tract hypoplasia, male 25.15 10.66 4 54582 0 79689802
Late onset hypogonadism syndrome 25.15 10.66 4 54582 0 79689802
Teratospermia 25.15 10.66 4 54582 0 79689802
Perineal pain 24.99 10.66 13 54573 1069 79688733
Prostatomegaly 24.93 10.66 20 54566 3463 79686339
Orgasmic sensation decreased 24.47 10.66 6 54580 49 79689753
Penile exfoliation 24.43 10.66 7 54579 109 79689693
Seminoma 24.26 10.66 8 54578 203 79689599
Illusion 24.18 10.66 15 54571 1726 79688076
Fibromyalgia 24.18 10.66 7 54579 64333 79625469
Product use issue 24.09 10.66 69 54517 209753 79480049
Agitation 24.02 10.66 133 54453 99582 79590220
C-reactive protein increased 23.86 10.66 32 54554 128995 79560807
Confusional state 23.86 10.66 327 54259 317670 79372132
Floppy iris syndrome 23.56 10.66 9 54577 354 79689448
Haemoglobin decreased 23.53 10.66 244 54342 221875 79467927
Somatic symptom disorder 23.52 10.66 17 54569 2520 79687282
Wound 23.39 10.66 27 54559 116152 79573650
Cerebrovascular accident 23.31 10.66 184 54402 155108 79534694
Muscle injury 23.03 10.66 3 54583 48558 79641244
Trans-sexualism 22.91 10.66 4 54582 3 79689799
C-reactive protein abnormal 22.91 10.66 3 54583 48364 79641438
Atrioventricular block first degree 22.89 10.66 35 54551 12456 79677346
Testicular swelling 22.66 10.66 13 54573 1297 79688505
Product administration error 22.56 10.66 60 54526 31786 79658016
Myopathy 22.56 10.66 46 54540 20517 79669285
Plica syndrome 22.38 10.66 4 54582 4 79689798
Nasopharyngitis 22.08 10.66 94 54492 253787 79436015
On and off phenomenon 21.91 10.66 18 54568 3222 79686580
Testicular cyst 21.59 10.66 5 54581 31 79689771
Prostatic haemorrhage 21.56 10.66 7 54579 169 79689633
Hypogonadism 21.55 10.66 14 54572 1746 79688056
Intentional overdose 20.92 10.66 25 54561 105935 79583867
Malpositioned teeth 20.59 10.66 5 54581 39 79689763
Soft tissue mass 20.21 10.66 12 54574 1276 79688526
Xanthopsia 20.20 10.66 8 54578 347 79689455
Exostosis of external ear canal 20.15 10.66 4 54582 10 79689792
Obstructive airways disorder 20.03 10.66 57 54529 31402 79658400
Sprue-like enteropathy 19.96 10.66 12 54574 1306 79688496
Splenomegaly 19.96 10.66 44 54542 20710 79669092
Glomerular filtration rate abnormal 19.91 10.66 13 54573 1635 79688167
Skin irritation 19.90 10.66 31 54555 11209 79678593
Melanocytic hyperplasia 19.87 10.66 4 54582 11 79689791
Drug abuse 19.80 10.66 52 54534 162639 79527163
Bradyphrenia 19.76 10.66 30 54556 10610 79679192
Interstitial lung disease 19.75 10.66 29 54557 112571 79577231
Irritable bowel syndrome 19.62 10.66 9 54577 62232 79627570
Varicocele 19.61 10.66 4 54582 12 79689790
Haemorrhage urinary tract 19.48 10.66 15 54571 2446 79687356
Hypertrophy 19.48 10.66 10 54576 800 79689002
Bradycardia 19.46 10.66 159 54427 135398 79554404
Injection site erythema 19.46 10.66 15 54571 78182 79611620
Balance disorder 19.41 10.66 125 54461 98732 79591070
Semen discolouration 19.37 10.66 4 54582 13 79689789
Parkinsonism 19.27 10.66 38 54548 16546 79673256
Depression suicidal 19.25 10.66 18 54568 3824 79685978
Subdural haemorrhage 19.19 10.66 22 54564 5926 79683876
Gastrointestinal disorder 19.06 10.66 34 54552 122171 79567631
Androgen insensitivity syndrome 18.93 10.66 4 54582 15 79689787
Fear of crowded places 18.93 10.66 4 54582 15 79689787
Haemorrhagic stroke 18.91 10.66 30 54556 11016 79678786
Androgens abnormal 18.86 10.66 3 54583 0 79689802
Biotin deficiency 18.86 10.66 3 54583 0 79689802
Arthralgia 18.76 10.66 277 54309 571526 79118276
Penile curvature 18.72 10.66 4 54582 16 79689786
Inflammation 18.64 10.66 22 54564 93731 79596071
N-terminal prohormone brain natriuretic peptide abnormal 18.50 10.66 7 54579 268 79689534
Nipple pain 18.22 10.66 10 54576 916 79688886
Suicide attempt 18.11 10.66 18 54568 82914 79606888
Impaired healing 18.04 10.66 20 54566 87635 79602167
Feeling abnormal 17.87 10.66 177 54409 159022 79530780
Brain natriuretic peptide increased 17.82 10.66 26 54560 8874 79680928
Delusion of replacement 17.81 10.66 6 54580 163 79689639
Alveolar bone resorption 17.75 10.66 5 54581 73 79689729
Muscular weakness 17.70 10.66 178 54408 160551 79529251
Blunted affect 17.60 10.66 8 54578 489 79689313
Stenosis 17.53 10.66 14 54572 2408 79687394
Coronary artery stenosis 17.50 10.66 31 54555 12453 79677349
Hyperkalaemia 17.41 10.66 136 54450 114262 79575540
Product name confusion 17.41 10.66 6 54580 175 79689627
Full blood count abnormal 17.30 10.66 64 54522 40410 79649392
Orgasm abnormal 17.28 10.66 6 54580 179 79689623
Ophthalmoplegia 17.27 10.66 15 54571 2897 79686905
Blood creatine phosphokinase increased 17.16 10.66 90 54496 66000 79623802
Haematemesis 17.05 10.66 76 54510 52188 79637614
Red blood cell analysis abnormal 16.98 10.66 4 54582 27 79689775
Ageusia 16.84 10.66 36 54550 16596 79673206
Blood oestrogen abnormal 16.79 10.66 3 54583 3 79689799
Dermatitis artefacta 16.79 10.66 3 54583 3 79689799
Weight increased 16.76 10.66 116 54470 277270 79412532
Blood creatinine increased 16.73 10.66 171 54415 154886 79534916
Muscle disorder 16.57 10.66 20 54566 5687 79684115
Iris disorder 16.43 10.66 7 54579 366 79689436
Nipple disorder 16.42 10.66 6 54580 208 79689594
Subdural haematoma 16.30 10.66 53 54533 31381 79658421
Arthritis 16.15 10.66 34 54552 114846 79574956
Cardiac failure chronic 16.06 10.66 28 54558 11107 79678695
Urinary tract obstruction 16.01 10.66 18 54568 4747 79685055
Cognitive disorder 16.00 10.66 92 54494 69834 79619968
Obsessive-compulsive disorder 15.97 10.66 20 54566 5907 79683895
Anhedonia 15.96 10.66 33 54553 14865 79674937
Ill-defined disorder 15.93 10.66 13 54573 65862 79623940
Migraine 15.87 10.66 22 54564 87471 79602331
Oligospermia 15.59 10.66 4 54582 40 79689762
Red blood cell sedimentation rate increased 15.51 10.66 6 54580 45936 79643866
Haemorrhage intracranial 15.28 10.66 46 54540 26147 79663655
Completed suicide 15.23 10.66 102 54484 245665 79444137
Flat affect 15.20 10.66 12 54574 2029 79687773
Insomnia 15.20 10.66 244 54342 244926 79444876
Bladder cancer 15.08 10.66 38 54548 19488 79670314
Serotonin syndrome 15.01 10.66 6 54580 45021 79644781
Blood glucose increased 14.99 10.66 132 54454 114843 79574959
Ludwig angina 14.92 10.66 6 54580 271 79689531
Dissociation 14.92 10.66 16 54570 4005 79685797
Mucosal inflammation 14.74 10.66 18 54568 75562 79614240
Dementia Alzheimer's type 14.72 10.66 9 54577 1010 79688792
Alcohol intolerance 14.67 10.66 7 54579 478 79689324
Lower respiratory tract infection 14.46 10.66 43 54543 129177 79560625
Cataract operation complication 14.44 10.66 6 54580 295 79689507
Phlebosclerosis 14.43 10.66 5 54581 148 79689654
Social avoidant behaviour 14.19 10.66 17 54569 4797 79685005
Renal atrophy 14.18 10.66 11 54575 1814 79687988
Retrograde ejaculation 14.17 10.66 6 54580 309 79689493
Genital cyst 14.16 10.66 4 54582 59 79689743
Iron metabolism disorder 14.16 10.66 4 54582 59 79689743
Infection 14.15 10.66 102 54484 241610 79448192
Mood altered 14.06 10.66 35 54551 17812 79671990
Spermatozoa progressive motility decreased 14.04 10.66 4 54582 61 79689741
Patellofemoral pain syndrome 14.03 10.66 7 54579 527 79689275
Ventricular extrasystoles 13.83 10.66 37 54549 19667 79670135
Febrile neutropenia 13.76 10.66 97 54489 230902 79458900
Blood luteinising hormone decreased 13.75 10.66 5 54581 171 79689631
Full blood count decreased 13.71 10.66 45 54541 26774 79663028
Listless 13.69 10.66 15 54571 3846 79685956
Hospice care 13.66 10.66 25 54561 10299 79679503
Epididymitis 13.64 10.66 11 54575 1919 79687883
Premature ejaculation 13.64 10.66 4 54582 68 79689734
Myalgia 13.54 10.66 190 54396 185451 79504351
Otosalpingitis 13.50 10.66 3 54583 15 79689787
Alpha 2 globulin decreased 13.50 10.66 3 54583 15 79689787
Sex hormone binding globulin decreased 13.50 10.66 3 54583 15 79689787
Paternal drugs affecting foetus 13.50 10.66 3 54583 15 79689787
Testicular microlithiasis 13.50 10.66 3 54583 15 79689787
Testicular mass 13.37 10.66 4 54582 73 79689729
Free androgen index decreased 13.34 10.66 3 54583 16 79689786
Bursitis 13.28 10.66 4 54582 35840 79653962
Immunodeficiency common variable 13.28 10.66 6 54580 362 79689440
Breast enlargement 13.27 10.66 10 54576 1579 79688223
Strangury 13.25 10.66 5 54581 190 79689612
Hip arthroplasty 13.23 10.66 4 54582 35752 79654050
Haematuria traumatic 13.20 10.66 5 54581 192 79689610
Anti factor Xa activity decreased 13.04 10.66 3 54583 18 79689784
Withdrawal hypertension 13.03 10.66 6 54580 378 79689424
Injection site reaction 13.02 10.66 11 54575 54774 79635028
Hypotrichosis 12.91 10.66 5 54581 204 79689598
Borderline personality disorder 12.91 10.66 8 54578 919 79688883
Multiple organ dysfunction syndrome 12.75 10.66 41 54545 120205 79569597
Blood oestrogen increased 12.71 10.66 4 54582 87 79689715
Mitochondrial cytopathy 12.66 10.66 6 54580 404 79689398
Fat tissue increased 12.65 10.66 8 54578 952 79688850
Bladder stenosis 12.64 10.66 3 54583 21 79689781
Atrial flutter 12.63 10.66 38 54548 21587 79668215
Exposure via father 12.63 10.66 4 54582 89 79689713
Mental impairment 12.62 10.66 35 54551 19001 79670801
Fatigue 12.54 10.66 766 53820 928961 78760841
Urogenital haemorrhage 12.52 10.66 8 54578 969 79688833
Testicular germ cell tumour mixed 12.52 10.66 3 54583 22 79689780
Internal haemorrhage 12.46 10.66 22 54564 8811 79680991
Blood urea increased 12.37 10.66 66 54520 48724 79641078
Altered state of consciousness 12.30 10.66 61 54525 43761 79646041
Viral acanthoma 12.29 10.66 3 54583 24 79689778
Peyronie's disease 12.29 10.66 3 54583 24 79689778
Gastrooesophageal reflux disease 12.23 10.66 117 54469 104129 79585673
Cytomegalovirus infection 12.20 10.66 7 54579 42637 79647165
Overdose 12.15 10.66 75 54511 184131 79505671
Bundle branch block right 12.14 10.66 25 54561 11226 79678576
Peritoneal neoplasm 12.11 10.66 4 54582 102 79689700
Blood testosterone abnormal 12.08 10.66 5 54581 243 79689559
Basosquamous carcinoma 12.07 10.66 4 54582 103 79689699
Nocturia 12.04 10.66 28 54558 13653 79676149
Myxoedema coma 11.92 10.66 7 54579 730 79689072
Product use in unapproved indication 11.77 10.66 112 54474 250247 79439555
Renal cyst 11.72 10.66 29 54557 14703 79675099
Prostatic operation 11.67 10.66 5 54581 265 79689537
Disseminated intravascular coagulation 11.59 10.66 5 54581 35837 79653965
Blood cholesterol increased 11.58 10.66 25 54561 83695 79606107
Product dispensing error 11.51 10.66 27 54559 13236 79676566
Vitreous floaters 11.46 10.66 19 54567 7237 79682565
Asbestosis 11.43 10.66 4 54582 122 79689680
Infusion site induration 11.43 10.66 8 54578 1127 79688675
Dyspnoea at rest 11.37 10.66 19 54567 7283 79682519
Feminisation acquired 11.35 10.66 3 54583 34 79689768
Myasthenia gravis 11.10 10.66 23 54563 10376 79679426
Cryptorchism 11.04 10.66 3 54583 38 79689764
Sexually inappropriate behaviour 11.04 10.66 6 54580 539 79689263
Nasal discomfort 10.95 10.66 16 54570 5467 79684335
Heparin-induced thrombocytopenia test positive 10.94 10.66 4 54582 139 79689663
Gingival disorder 10.94 10.66 13 54573 3638 79686164
Sinus rhythm 10.93 10.66 7 54579 851 79688951
Gingivitis 10.88 10.66 21 54565 9000 79680802
Affective disorder 10.82 10.66 20 54566 8299 79681503
Bladder dilatation 10.76 10.66 10 54576 2109 79687693
Genital burning sensation 10.74 10.66 5 54581 323 79689479
Mesenteric vascular insufficiency 10.73 10.66 4 54582 147 79689655
Parkinson's disease 10.71 10.66 9 54577 1662 79688140

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC D11AX10 DERMATOLOGICALS
OTHER DERMATOLOGICAL PREPARATIONS
OTHER DERMATOLOGICAL PREPARATIONS
Other dermatologicals
ATC G04CA51 GENITO URINARY SYSTEM AND SEX HORMONES
UROLOGICALS
DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
Alpha-adrenoreceptor antagonists
ATC G04CA55 GENITO URINARY SYSTEM AND SEX HORMONES
UROLOGICALS
DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
Alpha-adrenoreceptor antagonists
ATC G04CB01 GENITO URINARY SYSTEM AND SEX HORMONES
UROLOGICALS
DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
Testosterone-5-alpha reductase inhibitors
ATC G04CB51 GENITO URINARY SYSTEM AND SEX HORMONES
UROLOGICALS
DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
Testosterone-5-alpha reductase inhibitors
FDA MoA N0000000126 5-alpha Reductase Inhibitors
CHEBI has role CHEBI:35497 antiandrogen
CHEBI has role CHEBI:50781 5alpha-reductase inhibitors
CHEBI has role CHEBI:59844 antihyperplasia drugs
FDA EPC N0000175836 5-alpha Reductase Inhibitor
MeSH PA D058891 5-alpha Reductase Inhibitors
MeSH PA D004791 Enzyme Inhibitors
MeSH PA D006727 Hormone Antagonists
MeSH PA D065088 Steroid Synthesis Inhibitors
MeSH PA D064804 Urological Agents

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Benign prostatic hyperplasia indication 266569009
Male Patterned Baldness indication
Hidradenitis suppurativa off-label use 59393003 DOID:2280
Disease of liver contraindication 235856003 DOID:409
Pregnancy, function contraindication 289908002
Breastfeeding (mother) contraindication 413712001
High-Grade Prostate Cancer contraindication
Breast Carcinoma in Males contraindication




๐Ÿถ Veterinary Drug Use

None

๐Ÿถ Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 13.26 acidic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])
Mechanism
action
Bioact sourceMoA source
3-oxo-5-alpha-steroid 4-dehydrogenase 2 Enzyme INHIBITOR IC50 8.26 WOMBAT-PK DRUG LABEL
3-oxo-5-alpha-steroid 4-dehydrogenase 1 Enzyme INHIBITOR IC50 7.58 WOMBAT-PK DRUG LABEL
3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1 Enzyme Ki 4.96 CHEMBL
Cytochrome P450 2C9 Enzyme IC50 5.70 DRUG MATRIX
Cytochrome P450 2C19 Enzyme IC50 6 DRUG MATRIX
3-oxo-5-alpha-steroid 4-dehydrogenase 1 Enzyme Ki 8.17 CHEMBL
Steroid 5-alpha-reductase Enzyme Ki 7.26 CHEMBL
3-oxo-5-alpha-steroid 4-dehydrogenase 2 Enzyme IC50 9.55 CHEMBL

External reference:

IDSource
4020167 VUID
N0000148118 NUI
D00321 KEGG_DRUG
4020167 VANDF
C0060389 UMLSCUI
CHEBI:5062 CHEBI
FIT PDB_CHEM_ID
CHEMBL710 ChEMBL_ID
DB01216 DRUGBANK_ID
D018120 MESH_DESCRIPTOR_UI
57363 PUBCHEM_CID
6818 IUPHAR_LIGAND_ID
6539 INN_ID
57GNO57U7G UNII
219462 RXNORM
11509 MMSL
4728 MMSL
82773 MMSL
d00563 MMSL
003665 NDDF
109035006 SNOMEDCT_US
386963006 SNOMEDCT_US

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
PROPECIA HUMAN PRESCRIPTION DRUG LABEL 1 0006-0071 TABLET, FILM COATED 1 mg ORAL NDA 28 sections
PROSCAR HUMAN PRESCRIPTION DRUG LABEL 1 0006-0072 TABLET, FILM COATED 5 mg ORAL NDA 28 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 0093-7355 TABLET, FILM COATED 5 mg ORAL ANDA 27 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 0093-7355 TABLET, FILM COATED 5 mg ORAL ANDA 27 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 0904-6830 TABLET, FILM COATED 5 mg ORAL ANDA 26 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 0904-6830 TABLET, FILM COATED 5 mg ORAL ANDA 26 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 16729-089 TABLET, FILM COATED 1 mg ORAL ANDA 28 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 16729-089 TABLET, FILM COATED 1 mg ORAL ANDA 28 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 16729-089 TABLET, FILM COATED 1 mg ORAL ANDA 28 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 16729-090 TABLET, FILM COATED 5 mg ORAL ANDA 27 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 16729-090 TABLET, FILM COATED 5 mg ORAL ANDA 27 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 16729-090 TABLET, FILM COATED 5 mg ORAL ANDA 27 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 17856-0090 TABLET, FILM COATED 5 mg ORAL ANDA 26 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 31722-525 TABLET, FILM COATED 5 mg ORAL ANDA 22 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 31722-525 TABLET, FILM COATED 5 mg ORAL ANDA 22 sections
Finasteride Human Prescription Drug Label 1 31722-526 TABLET, FILM COATED 1 mg ORAL ANDA 26 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 33261-833 TABLET 5 mg ORAL ANDA 27 sections
Finasteride Human Prescription Drug Label 1 35573-400 TABLET, FILM COATED 1 mg ORAL ANDA 26 sections
Finasteride Human Prescription Drug Label 1 35573-400 TABLET, FILM COATED 1 mg ORAL ANDA 26 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 43598-303 TABLET, FILM COATED 5 mg ORAL ANDA 26 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 43598-390 TABLET, FILM COATED 1 mg ORAL ANDA 25 sections
Finasteride Human Prescription Drug Label 1 47335-714 TABLET, FILM COATED 1 mg ORAL ANDA 26 sections
Finasteride Human Prescription Drug Label 1 47335-714 TABLET, FILM COATED 1 mg ORAL ANDA 26 sections
FINASTERIDE Human Prescription Drug Label 1 47335-715 TABLET, FILM COATED 5 mg ORAL ANDA 26 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 50090-1718 TABLET, FILM COATED 5 mg ORAL ANDA 26 sections
Finasteride Human Prescription Drug Label 1 50090-1936 TABLET, FILM COATED 5 mg ORAL ANDA 26 sections
Finasteride Human Prescription Drug Label 1 50090-1936 TABLET, FILM COATED 5 mg ORAL ANDA 26 sections
Finasteride Human Prescription Drug Label 1 50090-1936 TABLET, FILM COATED 5 mg ORAL ANDA 26 sections
Finasteride HUMAN PRESCRIPTION DRUG LABEL 1 50090-3942 TABLET, FILM COATED 1 mg ORAL ANDA 27 sections
Finasteride Human Prescription Drug Label 1 50090-4648 TABLET, COATED 1 mg ORAL ANDA 25 sections